GPT and diabetes mellitus: Eleven patients reported a serious AE (SAE); the events were considered drug-related in three patients (grade 3 ALT/grade 2 AST increase/grade 2 C-reactive protein increase in one patient, grade 2 AST/ALT increase in one patient, and grade 3 diabetes mellitus in one patient).